ArticleRedox biology2025

Corrigendum to "FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms" [Redox Biol. 80 (2025) 103527].

Manish Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.